SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockDoc who wrote (515)5/4/1998 10:08:00 PM
From: Bob Rudd  Read Replies (1) of 2135
 
What probability would you estimate that ENMD has cure approved within 3-5 years?

I'd guess 25% based on Watson's enthusiasm, the mice results, & the long odds base rates

Any clue what share of revenues ENMD would get of total revenues of an approved drug (Considering BMY & Boston Children's Hospital will definitely participate)?
I'm guessing 10 % on this.

I put together valuation spreadsheet on ENMD and your $100 guestimate is quite plausible if my guestimates above are realistic
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News